These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19183313)

  • 1. Treatment of chronic diabetic foot ulcers with bemiparin: a randomized, triple-blind, placebo-controlled, clinical trial.
    Rullan M; Cerdà L; Frontera G; Masmiquel L; Llobera J
    Diabet Med; 2008 Sep; 25(9):1090-5. PubMed ID: 19183313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers.
    Martínez-de Jesús FR; Morales-Guzmán M; Castañeda M; Pérez-Morales A; García-Alonso J; Mendiola-Segura I
    Arch Med Res; 1997; 28(1):95-9. PubMed ID: 9078595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial.
    Blume PA; Walters J; Payne W; Ayala J; Lantis J
    Diabetes Care; 2008 Apr; 31(4):631-6. PubMed ID: 18162494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes.
    Tom WL; Peng DH; Allaei A; Hsu D; Hata TR
    Arch Dermatol; 2005 Nov; 141(11):1373-7. PubMed ID: 16301384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers.
    Jude EB; Apelqvist J; Spraul M; Martini J;
    Diabet Med; 2007 Mar; 24(3):280-8. PubMed ID: 17305788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study.
    Lyons TE; Miller MS; Serena T; Sheehan P; Lavery L; Kirsner RS; Armstrong DG; Reese A; Yankee EW; Veves A
    Am J Surg; 2007 Jan; 193(1):49-54. PubMed ID: 17188087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream.
    Lipsky BA; Holroyd KJ; Zasloff M
    Clin Infect Dis; 2008 Dec; 47(12):1537-45. PubMed ID: 18990064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study.
    Santamaría A; Juárez S; Reche A; Gómez-Outes A; Martínez-González J; Fontcuberta J;
    Int J Clin Pract; 2006 May; 60(5):518-25. PubMed ID: 16700847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers.
    Arosio E; Ferrari G; Santoro L; Gianese F; Coccheri S;
    Eur J Vasc Endovasc Surg; 2001 Oct; 22(4):365-72. PubMed ID: 11563899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial.
    Squadrito F; Bitto A; Altavilla D; Arcoraci V; De Caridi G; De Feo ME; Corrao S; Pallio G; Sterrantino C; Minutoli L; Saitta A; Vaccaro M; Cucinotta D
    J Clin Endocrinol Metab; 2014 May; 99(5):E746-53. PubMed ID: 24483158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study.
    Ennis WJ; Foremann P; Mozen N; Massey J; Conner-Kerr T; Meneses P
    Ostomy Wound Manage; 2005 Aug; 51(8):24-39. PubMed ID: 16234574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer.
    UCHI H; IGARASHI A; URABE K; KOGA T; NAKAYAMA J; KAWAMORI R; TAMAKI K; HIRAKATA H; OHURA T; FURUE M
    Eur J Dermatol; 2009; 19(5):461-8. PubMed ID: 19638336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up.
    Uccioli L; Giurato L; Ruotolo V; Ciavarella A; Grimaldi MS; Piaggesi A; Teobaldi I; Ricci L; Scionti L; Vermigli C; Seguro R; Mancini L; Ghirlanda G
    Int J Low Extrem Wounds; 2011 Jun; 10(2):80-5. PubMed ID: 21693443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile and management outcome of diabetic foot ulcers in a tertiary care hospital.
    Mehmood K; Akhtar ST; Talib A; Talib A; Abbasi B; Siraj-ul-Salekeen ; Naqvi IH
    J Coll Physicians Surg Pak; 2008 Jul; 18(7):408-12. PubMed ID: 18760063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers.
    Wainstein J; Feldbrin Z; Boaz M; Harman-Boehm I
    Diabetes Technol Ther; 2011 Dec; 13(12):1255-60. PubMed ID: 21751891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy.
    Morley S; Griffiths J; Philips G; Moseley H; O'Grady C; Mellish K; Lankester CL; Faris B; Young RJ; Brown SB; Rhodes LE
    Br J Dermatol; 2013 Mar; 168(3):617-24. PubMed ID: 23066973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new wound-based severity score for diabetic foot ulcers: A prospective analysis of 1,000 patients.
    Beckert S; Witte M; Wicke C; Königsrainer A; Coerper S
    Diabetes Care; 2006 May; 29(5):988-92. PubMed ID: 16644625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Triple-blind clinical trial with placebo control to evaluate the efficacy of a heparin of low molecular weight (bemiparin) for treating slow-responding ulcers in diabetic foot in primary care].
    Rullán M; Cerdà L; Frontera G; Llobera J; Masmiquel L; Olea JL
    Aten Primaria; 2003 May; 31(8):539-44. PubMed ID: 12765594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.
    Hanft JR; Pollak RA; Barbul A; van Gils C; Kwon PS; Gray SM; Lynch CJ; Semba CP; Breen TJ
    J Wound Care; 2008 Jan; 17(1):30-2, 34-7. PubMed ID: 18210954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulceration.
    Weck M; Rietzsch H; Lawall H; Pichlmeier U; Bramlage P; Schellong S
    Thromb Haemost; 2008 Sep; 100(3):475-82. PubMed ID: 18766265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.